Anybody know of similar cases in the past where ot

Anybody know of similar cases in the past where other medical centers or universities asked to conduct thier own studies on a drug still in PHASE studies like KEVETRIN is now ?

Also in the case of KEVETRIN they are not going to conduct the exact same PHASE I as what is at DANA-FABER , so its like a totally new PHASE I and they would not be concidered the same collectively, I would think. Not that there is anything wrong with that , just finding different applications quicker but each would have to get a seperate FDA approval if I understand it right.